© Reuters. The logo of Stellantis, the world’s fourth-largest automaker which starts trading in Milan and Paris after Fiat Chrysler and Peugeot maker PSA finalised their merger, is seen on a flag at the main entrance of FCA Mirafiori plant in Turin, Italy, January 1
MILAN (Reuters) – Vehicle production from sites owned in Italy by Stellantis and previously its predecessor Fiat Chrysler is set to fall for a fifth consecutive year in 2022 due to the microchip supply crunch, the FIM CISL union said on Wednesday.
Fiat Chrysler and Peugeout-maker PSA merged at the start of last year to form Stellantis, the world’s fourth-largest carmaker. At the time of the merger PSA did not have any production facilities in Italy.
FIM CISL said overall Stellantis production in Italy fell 13.5% year-on-year in the first quarter due to the semiconductor shortage, which is weighing in particular on the Melfi and Sevel plants, two of the group’s main sites in the country.
In particular, car production fell 2.6% to 123,484 units, while van production fell 30.4% to 56,690, it added.
Melfi covers around 40% of Stellantis car production in Italy, while Sevel is Europe’s largest van production plant.
FIM CISL Head Ferdinando Uliano said exceptional factors such as the coronavirus pandemic and the ongoing chip shortage were becoming a constant.
“The war in Ukraine is having an impact on supplies,” he said while presenting the union’s quarterly report on Stellantis production in Italy.
“There was hope that 2022 could mark an improvement on semiconductors and raw material supplies, but we now doubt this can happen,”
FIM CISL said that based on trends seen in the three months, 2022 production could fall below 600,000 vehicles, with cars amounting to less than 400,000 units.
That would mark a fifth consecutive year of declining output, including COVID-hit 2020, and compares with a total of over 1 million vehicles leaving the assembly lines in 2017, the last time Fiat Chrysler reported rising annual production in Italy.
Stellantis declined to comment.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment